key: cord-0702764-vcinz7y5
authors: Hirade, Tomohiro; Moriyama, Aisa; Wada, Keisuke; Nakashima, Shigeki; Taketani, Takeshi
title: Idiopathic pulmonary hemosiderosis: A mimic of severe COVID‐19 pneumonia
date: 2022-02-28
journal: Pediatr Int
DOI: 10.1111/ped.14991
sha: 7a61aa1c0509a7a31267707acd0b1746d47ea312
doc_id: 702764
cord_uid: vcinz7y5

nan

the diagnosis. Refractory anemia and failure to thrive are suggestive of IPH. 6 Other than conducting a lung biopsy to diagnose IPH, identification of siderophages in the sputum, bronchoalveolar lavage, or gastric aspirate is helpful for diagnosis if other pulmonary hemorrhagic diseases are excluded. 6 Systemic corticosteroid treatment improves IPH prognosis. 7 

Idiopathic pulmonary hemosiderosis: A state of the art review

New insights into pediatric idiopathic pulmonary hemosiderosis: The French RespiRare â cohort

A review of clinical and imaging features of diffuse pulmonary hemorrhage

Coronavirus disease 2019 (COVID-19) in children: A systematic review of imaging findings

Review of the chest CT differential diagnosis of ground-glass opacities in the covid era

Nelson Textbook of Pediatrics

Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis

We thank Dr Hiroshi Watanabe, Watanabe Children Women Clinic, Shimane, Japan, for taking care of the patient.

The authors declare no conflict of interest.

T.H. is the main author and wrote the manuscript; A.M., K.W., and S.N. were responsible for diagnosing and treating the patient; T.T. critically reviewed the manuscript and supervised the study process. All authors read and approved the final manuscript.

This report was reviewed and approved by the appropriate ethics committee. Written informed consent was obtained from the parents of the patient for publication of this report.